RAC 3.31% $1.61 race oncology ltd

Ann: Zantrene AML trial in Israel advances to Phase 2, page-120

  1. 130 Posts.
    lightbulb Created with Sketch. 326
    Hey @Davisite, haven’t you figured out yet, if you,

    apply thought, diligence and scientific effort into a company that maybe has some flaws, you’re “shitbagging”

    apply thought, diligence and scientific thought into a company that has some real positives you’re “pumping”

    seriously, how can you win???
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.